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Abstract
The ArsAB ATPase confers metalloid resistance in Escherichia coli by pumping toxic anions out of the cells. This transport
ATPase shares structural and perhaps mechanism features with ABC transporters. The ArsAB pump is composed of a
membrane subunit that has two groups of six transmembrane segments, and the catalytic subunit, the ArsA ATPase. As is
the case with many ABC transporters, ArsA has an internal repeat, each with an ATP binding domain, and is allosterically
activated by substrates of the pump. The mechanism of allosteric activation of the ArsA ATPase has been elucidated at the
molecular level. Binding of the activator produces a conformational change that forms a tight interface of the nucleotide
binding domains. In the rate-limiting step in the overall reaction, the enzyme undergoes a slow conformational change. The
allosteric activator accelerates catalysis by increasing the velocity of this rate-limiting step. We postulate that similar
conformational changes may be rate-limiting in the mechanism of ABC transporters. ß 1999 Elsevier Science B.V. All
rights reserved.
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1. Introduction
All organisms, prokaryotic, eukaryotic or archea,
have evolved resistances to drugs and toxic metals. It
is likely that life evolved in waters rich in dissolved
metals and metalloids, such as arsenic. Thus resis-
tance to toxic metal ions probably evolved early,
vastly predating the evolution of drug resistance. In
Escherichia coli, high level resistance to the salts of
the trivalent metalloids arsenite and antimonite is
conferred by the ars operon of plasmid R773 [1].
The arsA and arsB genes encode the subunits of
the ArsAB As(III)/Sb(III)-translocating ATPase,
which extrudes the metalloid oxyanions (Fig. 1).
ArsB is the 45-kDa membrane sector of the pump,
and has 12 membrane spanning segments. ArsA, the
catalytic sector of the pump, is normally bound to
ArsB, but, when expressed in the absence of ArsB,
ArsA can be puri¢ed as a soluble ATPase. The 63-
kDa ArsA ATPase has two homologous halves, A1
and A2, connected by a 25-residue linker peptide.
Each half has a consensus nucleotide binding domain
(NBD), both of which are required for activity. The
enzyme is allosterically activated by binding of
As(III) or Sb(III). The mechanism by which drugs
activate the e¥ux pumps that confer resistance to
those drugs is a major unanswered question in the
¢eld of resistance. In this chapter, the mechanism of
allosteric activation of ArsA is described. The rela-
tionship of the allosteric and nucleotide binding do-
mains has been elucidated, and a reaction scheme has
been proposed.
2. The nucleotide binding domains
The ¢rst indication that the R773 ars operon en-
coded a primary ATP-coupled pump was from an in
vivo analysis of the energetics of arsenical e¥ux [2].
In intact cells of E. coli, a primary pump is depen-
dent on intracellular chemical energy, while a sec-
ondary porter requires electrochemical energy. This
study was performed in an unc strain that is defective
in the H-translocating ATPase (FoF1) and is thus
unable to equilibrate chemical and electrochemical
energy. In the presence of both glucose, which gen-
erates ATP through glycolysis, and cyanide, which
inhibits respiratory-driven formation of an electro-
chemical potential, e¥ux was rapid. In the presence
of respiratory substrates that form an electrochemi-
cal potential but not ATP, e¥ux was slow. These
results are consistent with the operon encoding an
obligatorily ATP-coupled pump. The operon was
subsequently cloned and sequenced [3]. The sequence
demonstrated that the arsA gene encoded a protein
of 583 residues that had an internal repeat of approx-
imately 30 kDa each (Fig. 2). Each half, termed A1
and A2, has a consensus nucleotide binding domain
(NBD). ArsA was puri¢ed and demonstrated to have
arsenite- or antimonite-stimulated ATPase activity
[4]. Mutations in either A1 or A2 NBD resulted in
loss of resistance, loss of transport and loss of ATP-
ase activity [5,6]. Finally, everted membrane vesicles
with the ArsAB complex exhibited ATP-coupled ac-
cumulation of 73AsO312 [7]. Thus ArsAB is an arsen-
ite/antimonite-translocating ATPase.
Why do many transport ATPases, including ABC
transporters, require two or more nucleotide binding
domains? From genetic results it appears that the
two sites in ArsA interact [8]. The codon for Gly-
15 in A1 NBD was mutated to a cysteine codon (Fig.
2). Cells expressing the arsAG15C mutation resulted in
substantial reductions in arsenite resistance, trans-
port and ATPase activity. Mutants were selected
that suppressed the arsenite-sensitive phenotype of
the G15C mutation. One mutation that restored ar-
senite resistance was a substitution of valine for Ala-
344 which is located adjacent to A2 NBD binding
sequence, indicating spatial proximity of Gly-15 and
Ala-344. These data support a model in which inter-
action of the two NBDs promotes catalysis (Fig. 3).
Alteration of Ala-344 to bulkier residues also sup-
pressed substitutions in the A1 NBD [9]. Less bulky
residues, such as glycine or serine, did not e⁄ciently
suppress primary A1 NBD mutations. Thus, the
larger the residue, the greater the suppression. The
altered ArsAs were puri¢ed, and a relationship was
observed between activity and residue volume.
Each altered enzyme exhibited both an increase in
the Km for ATP and in the concentration of anti-
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monite required for half maximal allosteric activa-
tion. The results are consistent with a physical inter-
action of the two NBDs and indicate that the geom-
etry at the interface between A1 and A2 NBDs
impose steric constraints on allowable residues in
that interface.
Mg2 is essential for ATPase activity of ArsA [10].
An e¡ect of Mg2 on the conformation of ArsA was
observed only in the presence of ATP, suggesting
that Mg2 binds to ArsA as a complex with ATP
[11]. Coordination of Mg2 in ATP- and GTP-bind-
ing proteins frequently involves aspartate residues.
ArsA has several aspartate residues that are highly
conserved in homologs and in other nucleotide bind-
ing enzymes such as the nitrogenase iron protein
(NifH) [12], RecA [13], and GTP-binding proteins,
including Ras p21 [14]. In Ras p21 the conserved
Asp residues are Mg2 ligands [14]. The magnesium
ion was shown to bring together diverse components
of the GTP-binding core, facilitating the information
£ow between domains. ArsA residue 45 is a con-
served aspartic acid. To examine the role of Asp-
45, mutants were constructed in which Asp-45 was
changed to Glu, Asn, or Ala [10]. Cells expressing
those mutated arsA genes have reduced arsenite re-
sistance. Puri¢ed D45A and D45N ArsAs were inac-
tive, while the puri¢ed D45E ArsA exhibited approx-
imately 5% of the wild-type activity, with about 5-
fold decrease in a⁄nity for Mg2. These results in-
dicate that an aspartate residue at position 45 pro-
motes catalytic activity. Moreover, Mg2 produces
conformational changes in ArsA that can be detected
from the e¡ect of the cation on the surface accessi-
bility of the protein to trypsin or on the intrinsic
£uorescence of Trp-159. These results strongly sug-
gest that Asp-45 is a Mg2 ligand.
Fig. 1. The ArsAB pump. The complex of ArsA and ArsB forms an anion-translocating ATPase that catalyzes extrusion of arsenite
or antimonite. ArsA has two homologous halves, A1 (N-terminal) and A2 (C-terminal). ArsA is the catalytic subunit, exhibiting
As(III)/Sb(III)-stimulated ATPase activity. ArsB is an inner membrane protein in E. coli and serves both as the membrane anchor for
ArsA and as the anion conducting subunit of this ATP-coupled pump.
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3. The allosteric site
ArsA ATPase activity has been shown to be spe-
ci¢cally activated by antimonite (Sb(III)) or arsenite
(As(III)). In the absence of metalloid ion, ArsA has a
low level of ATPase activity. Sb(III) stimulates ATP
hydrolysis 10- to 20-fold, while a 3- to 5-fold stim-
ulation is observed with As(III). Other oxyanions
tested were neither stimulatory nor inhibitory [15].
It was possible that activation of ArsA by arsenite
or antimonite might be through binding of these
compounds as oxyanions to anion binding sites.
However, as metalloids, they might react as soft met-
als through coordinate interactions with cysteine thi-
Fig. 2. ArsA primary sequence model. Top: the 583-amino acid residue ArsA ATPase consists of two homologous halves, N-terminal
A1 and C-terminal A2, connected by a 25-residue linker sequence. The aligned boxes in the two halves indicate the regions of greatest
sequence similarity. Shown are the P-loop of the A1 and A2 NBDs (shaded). Indicated are the locations of Gly-15 in the A1 NBD
and Ala-344 in the A2 NBD and the three cysteine residues in the allosteric binding site. Also shaded are the two DTAP domains,
with the A1 sequence bounded by Phe-141 and Trp-159. Bottom: conserved residues in the DTAP consensus sequences in nucleotide
binding proteins are shaded. Phe-141 and Trp-159 are underlined. Shown are sequences from the A1 and A2 halves of ArsA, and ho-
mologs from Chlorobium vibrioforme (U09867), Saccharomyces cerevisiae (S67642), Methanococcus jannaschii (E64442), Arabidopsis
thaliana (AB005246), Caenorhabditis elegans (P30632), Mus musculus (AAB94772) and Homo sapiens (NP 004308). Accession numbers
are given in parentheses.
Fig. 3. Allosteric model of ArsA catalysis. Binding of e¡ector Sb(III) (or As(III)) to Cys-113, Cys-172, and Cys-422 (with the thiolates
represented as S) brings together the A1 and A2 NBDs of ArsA. This produces a large increase in the rate of the conformational
change that occurs in the DTAP domains during the catalytic cycle, promoting catalysis.
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olates. In the reaction of arsenite with thiolates, such
as dithiothreitol or glutathione, arsenic acts as a soft
metal, forming direct As^S bonds [16,17]. The ArsR
repressor binds either Sb(III) or As(III) as a soft
metal through interaction with three cysteinyl resi-
dues, and metalloid binding results in derepression
[18].
Therefore, if activation of ArsA by antimonite or
arsenite involves direct metal^sulfur bonds, then al-
teration of participating cysteine residues would be
expected to have a dramatic e¡ect on activation.
ArsA catalysis was found to be extremely sensitive
to sulfhydryl reagent, methyl methanethiosulfonate
(MMTS) [19]. MMTS reacts speci¢cally with thiol
groups on the surface of proteins, forming a disul¢de
between the cysteinyl residue and the small ^SCH3
group. A two-fold molar excess of MMTS over ArsA
rapidly and completely inactivated ArsA ATPase ac-
tivity. The MMTS-modi¢ed ArsA could be reacti-
vated to about 70% of its original activity upon ad-
dition of dithiothreitol. These data indicated that one
or more cysteines is involved in activation.
As(III) binds to spatially proximate thiol groups
[20]. This implies that for arsenite or antimonite to
activate ArsA, the protein would be expected to have
two or more cysteine residues in close proximity in
the tertiary structure, if not in the primary sequence.
In ArsA there are four cysteines, Cys-26, Cys-113,
Cys-172, and Cys-422, all located in di¡erent regions
of the primary sequence (Fig. 2). For arsenite or
antimonite to act as an allosteric modulator, two
or more of the cysteines must be close enough in
the folded protein to coordinate with the metalloid.
To investigate the role of cysteine residues in the
allosteric activation of ArsA, each of the four cys-
teines were altered to serine residues by site-directed
mutagenesis of the arsA gene [19]. Cells expressing
the arsAC26S mutant exhibited no change in resist-
ance to arsenite or antimonite, and the puri¢ed
C26S ArsA had wild-type ATPase activity. In con-
trast, cells expressing the arsAC113S, arsAC172S and
arsAC422S mutants were sensitive to arsenite or anti-
monite. Each of the three altered proteins exhibited
reduced arsenite or antimonite stimulated ATPase
activity. Substitution of each of the cysteines with
serine residues did not appear to grossly perturb
the tertiary structure of ArsA. The kinetic parame-
ters of the C26S ArsA were essentially the same as
that of wild-type protein. Thus, Cys-26 does not ap-
pear to be involved in either activation or catalysis.
Each cysteine-to-serine substituted protein was pro-
duced in normal amounts and exhibited the same
tryptic digestion patterns as the wild-type, indicating
that the altered proteins had relatively unaltered con-
formations. When the kinetic parameters of the pu-
ri¢ed C113S, C172S and C422S ArsAs were investi-
gated, the Km for ATP for each of the mutant was
found to be within an order of magnitude of the
wild-type enzyme. However, the concentration of
Sb(III) or As(III) required for activation was sub-
stantially increased, most likely re£ecting a decrease
in a⁄nity for metalloid. Alteration of Cys-422 ap-
peared to have more of an e¡ect than alteration of
Cys-113 or Cys-172. The C113S and C172S proteins
exhibited a 20-fold increase in the concentration of
antimonite required for half maximal activation,
while the C422S required 200-fold more. Similar re-
sults were observed when arsenite was used as the
activator. These results suggested that all three cys-
teines, Cys-113, Cys-172, and Cys-422 are involved in
activation.
Limited trypsin digestion experiments also sup-
ported the idea that the activator-binding site of
C113S, C172S and C422S was modi¢ed. Surface ac-
cessibility to trypsin has been used to assess the
structure of ArsA [15]. The e¡ect of ATP and oxy-
anions on the rate of trypsin digestion has been
shown to re£ect the binding of substrate and activa-
tor and the interaction of the two types of binding
sites in ArsA. The presence of both antimonite and
ATP has been shown to synergistically protect the
63-kDa wild-type ArsA protein [15]. The synergistic
e¡ect was observed with C26S but not C113S, C172S
or C422S. From those results it was proposed that
allosteric activation of ArsA ATPase occurs through
coordination of As(III) or Sb(III) by the cysteine
thiolates of residues 113, 172, and 422 (Fig. 3).
Although these three cysteines are located distant
from each other in the primary sequence, the data
imply that they come close together in the quater-
nary structure to interact with either As(III) or
Sb(III). From X-ray crystal data of As(III) or Sb(III)
complexed to small molecule dithiols, the lengths of
an As^S bond and Sb^S bond are 2.23 and 2.45 Aî ,
respectively, while S^As^S and S^Sb^S angles are
92.7‡ and 84.8‡, respectively [16,21]. Moreover, using
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a combination of site-directed mutagenesis and ar-
senic X-ray absorption spectroscopy, the ArsR re-
pressor was shown to bind As(III) to the thiolates
of the cysteine triad of Cys-32, Cys-34, and Cys-37
with As^S bonds of 2.25 Aî [22]. Thus, a reasonable
model for interaction of ArsA with As(III) or Sb(III)
would be coordination of the metalloid to the thio-
lates of Cys-113, Cys-172, and Cys-422, which re-
quires that the cysteines be in proximity with each
other in the folded protein. To examine this possibil-
ity, the homobifunctional cross-linker dibromobi-
mane (bBBr) was used to map distance between
pair of cysteines in ArsA. bBBr has two equivalent
bromomethyl groups that can cross-link a thiol pair
located within 3^6 Aî of each other [23]. bBBr is non-
£uorescent in solution, but becomes £uorescent
when both of its alkylating groups have reacted
[24]. This property allowed bBBr to be used as a
molecular ruler to map distance between cysteine
residues
An ArsA in which only one of the three essential
cysteine was altered by site-directed mutagenesis still
formed £uorescent adducts with dibromobimane.
Proteins in which two of the three essential cysteine
residues were substituted did not form £uorescent
adducts. These results demonstrated that Cys-113,
Cys-172, and Cys-422 are within 6 Aî from each other
in the native enzyme [25], suggesting that a novel
As(III)/Sb(III)-thiol structure is involved in allosteric
activation of ArsA. ArsA is the only known example
of an enzyme that requires As(III)/ Sb(III) for its
activity.
4. Interaction of the allosteric and catalytic sites
How does binding of the metalloid result in allo-
steric activation? As described above, the A1 and A2
NBDs interact to produce a high rate of catalysis. In
the absence of allosteric activator, A1 and A2 have
independent mobility, held together only by a 25-res-
idue £exible linker peptide. Coordination of As(III)
or Sb(III) with Cys-113 and Cys-172 in the A1 and
Cys-422 in A2 physically pulls the two halves of the
protein together. This in turn brings the two nucleo-
tide-binding sites in close contact with each other
and accelerating catalysis. The release of energy
from ATP hydrolysis in ArsA is transduced into
the ArsB subunit of the pump, thereby driving trans-
port of the metalloid oxyanions.
In addition to the movement of the A1 and A2
halves of the protein, there are more localized con-
formational changes that are propagated from the
allosteric domain to the NBDs. The changes are
mediated by the 12-residue consensus sequence
DTAPTGHTIRLL (termed the DTAP domain)
that is found in each half of ArsA and ArsA homo-
logs from eubacteria, archebacteria, fungi, plants and
animals, including humans (Fig. 2) [26]. Two ArsAs
were constructed with only a single tryptophan resi-
due, either Trp-141 or Trp-159, at either end of the
A1 DTAP domain (Fig. 2). Trp-159 is one of the
four native tryptophan residues in ArsA; in the mu-
tant, the other three were changed by mutagenesis to
phenylalanine residues. In the Trp-141 protein, all
native tryptophans had been changed to phenylala-
nines, and Phe-141 was altered to tryptophan by
mutagenesis. In the absence of ligands, the emission
spectrum of the £uorescence of Trp-159 indicated
that the C-terminal end of the DTAP domain is in
a relatively hydrophilic environment [10,26]. How-
ever, upon addition of MgATP there was an increase
in intrinsic tryptophan £uorescence and a blue shift
of the maximum emission wavelength, indicative of a
change in the environment of the domain into a rel-
atively less polar environment. This could be the re-
sult of a conformational change in the domain itself.
More likely, the domains are located on the surfaces
of the A1 and A2 halves that form an interface upon
binding of As(III). As the two halves come together,
the solvent accessibility of the DTAP domains is al-
tered.
Interestingly, no £uorescence response was ob-
served with MgADP, with non-hydrolyzable ATP
analogs, or with MgATP by inactive ArsAs. More-
over, the time course of the £uorescence change
agreed well with the rate of ATP hydrolysis, suggest-
ing that Trp-159 becomes less solvent accessible only
during hydrolysis of ATP. Addition of Sb(III) or
As(III) rapidly collapsed the ATP-enhanced £uores-
cence of Trp-159. Since the metalloids increase the
rate of catalysis, the data suggest a link between the
allosteric transition and the change in environment
of the DTAP domain. In contrast, Trp-141, located
on the N-terminal side of the A1 DTAP domain, is
in a relatively non-polar environment. Addition of
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MgADP decreased the £uorescence yield and red
shifted the maximum emission wavelength. While
MgATP slowly decreased Trp-141 £uorescence, the
rate correlated with product formation and was not
observed with non-hydrolyzable ATP analogs. These
results suggest that the N-terminal end of the DTAP
domain becomes exposed to a more polar environ-
ment upon product formation. Thus, the C-terminal
end of the A1 DTAP domain moves into a less polar
environment during catalysis, while the N-terminal
end moves into a more hydrophilic environment as
product is formed.
5. Reaction mechanism of the ArsA ATPase
While, in the aggregate, the results demonstrate
interaction between the two NBDs that is linked to
movement of the DTAP domain facilitated by bind-
ing of the allosteric e¡ector, what are the molecular
and enzymatic steps in activation and catalysis? The
kinetic mechanism of the ATPase reaction catalyzed
by ArsA has been studied by transient kinetic tech-
niques, and the data has been interpreted in terms of
the following multi-step kinetic scheme [27]:
The most notable feature of the mechanism is the
fact that the rate-limiting step for the reaction is a
conformational change, subsequent to hydrolysis and
product release, back to the original conformation
(e.g. step 7). The experimental evidence supporting
this mechanism is as follows:
1. An analysis of the steady-state kinetics yielded an
apparent kcat of 5.4U1033 s31.
2. The binding of MgATP to ArsA can be moni-
tored directly as a biphasic, increase and decrease,
in the intrinsic £uorescence of ArsA. The rate
constant for the ¢rst step (observed as an increase
in £uorescence) increases hyperbolically with the
MgATP concentration, while the rate constant for
the second step (observed as a decrease in £uores-
cence) is concentration independent. This behav-
ior is indicative of a three-step binding process,
with the rapid equilibrium binding of MgATP
(e.g. step 1, with a K1 of 178 WM) followed by
two rate-limiting isomerizations (e.g. steps 2 and
3). The ¢rst-order rate constants for these isomer-
izations of the ArsA^MgATP complex are k2 = 54
s31, k32 = 7.3 s31, k3+k33 = 6.5 s31. This cannot
be rate-limiting because they are much faster than
the steady-state rate.
3. There is a phosphate burst when ArsA is mixed
with MgATP. Since there can only be a pre-
steady-state product burst (e.g. a build-up of Pi
and MgADP on the ArsA) when the hydrolysis
steps are faster then subsequent steps (e.g. product
release or a conformational change linked to
product release) this data indicates that hydrolysis
of the MgATP is not rate-limiting. To determine
the amount of phosphate produced during the
burst phase, a photospectrometric assay was
used, which would only detect Pi released to the
bathing solution, rather than that complexed with
ArsA. Consequently, these data imply that neither
hydrolysis nor Pi dissociation are rate-limiting.
4. Because the MgATP^ArsA complex has greater
£uorescence than the MgADP^ArsA complex,
the dissociation rate constant for MgADP could
be measured directly by MgATP displacement.
This experiment yielded a value for k6 of 0.08
s31, which is too fast for MgADP release to be
rate-limiting.
5. Since neither hydrolysis nor product release is
rate-limiting, we conclude that a conformational
change at the end of the reaction, in which the
protein adopts its original conformational form
(e.g. ArsA1), is rate-limiting for the ATPase reac-
tion.
6. Stopped-£ow £uorescence studies revealed the
transient formation of a reaction intermediate
(with enhanced £uorescence) that was formed
over 100 s (e.g. k = 0.05 s31) and decayed over
1000 s (e.g. k = 2.3U1033 s31). The rates at which
this intermediate formed and decayed were inde-
pendent of the MgATP concentration, indicating
that its formation preceded the rate-limiting step.
A plausible interpretation for this observation is
that the intermediate is the ArsA^MgADPWPi
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complex. The rate of formation of the intermedi-
ate would then occur at the rate of hydrolysis of
ATP (e.g. k4 = 0.05 s31), and the intermediate
would decay as Pi is released from the ArsA^
MgADPWPi complex (e.g. k5 = 2.3U1033 s31).
There would then be a relatively rapid release of
ADP. An alternative proposal might be that step
4 involves both ATP hydrolysis and ADP release,
and that the intermediate is ArsA^Pi. However,
the intermediate is sensitive to EDTA, which
causes a decrease in the £uorescence back to the
baseline, consistent with destabilization of the
ArsA^MgADPWPi complex as the Mg2 is seques-
tered.
Interestingly, the Pi burst occurred at a rate ap-
proximately half that of kcat. A plausible explanation
for this behavior is that both the nucleotide-binding
sites of ArsA are catalytic. Consistent with this in-
terpretation, approximately 2 moles of phosphate are
released per mole of ArsA during the Pi burst.
When ArsA is equilibrated with antimonite prior
to mixing with MgATP, the stopped-£ow £uores-
cence pro¢le is characterized by a very rapid increase
in £uorescence, which is almost complete within the
dead-time of the stopped-£ow, followed by a rela-
tively rapid decrease in £uorescence back to the base-
line over 100 s. A reasonable interpretation for this
behavior is that ArsA does not need to undergo the
slow conformational change back to its original con-
formation in the presence of antimonite and, conse-
quently, there is no build-up of the ArsA^MgADPWPi
intermediate with enhanced £uorescence. The in-
crease in £uorescence is due to rapid formation of
the ArsA^MgATP complex, which undergoes rapid
hydrolysis and product release, and the £uorescence
returns to the basal level during this phase of the
reaction. Indeed, when ArsA is mixed with MgATP
and the ArsA^MgADPWPi intermediate, with en-
hanced £uorescence, is allowed to build up during
the ¢rst 100 s of the reaction, the addition of anti-
monite has the e¡ect of rapidly reversing the £uores-
cence enhancement within a second. This behavior is
consistent with the antimonite inducing the rapid
displacement of the ADP from the ArsA^MgADPWPi
complex. This rapid dissociation of ADP is not ob-
served when ArsA is pre-equilibrated with antimo-
nite before mixing with MgATP, presumably because
ADP dissociation is then rate-limited by ATP hy-
drolysis. Consistent with this view there is no phos-
phate burst in the presence of antimonite and kcat
increases by about an order of magnitude. A plausi-
ble explanation for this behavior is that antimonite
stabilizes a conformation of the enzyme from which
the products can dissociate rapidly.
6. Conclusions
While it is not clear how closely the ArsAB resist-
ance pump is related to ABC transporters, they share
structural and perhaps mechanistic features. The
ArsAB pump is composed of two types of subunits,
the 45-kDa ArsB membrane sector with two groups
of six transmembrane segments, and the catalytic
sector, the 63-kDa ArsA ATPase. As is the case
with many ABC transporters, ArsA has an internal
repeat, clearly the result of an ancestral gene dupli-
cation and fusion. Both the A1 and A2 halves have a
NBD, and both NBDs are required for resistance.
ArsA ATPase activity is allosterically activated by
the substrates of the pumps; similarly ABC trans-
porters exhibit increased ATPases activity in the
presence of their substrates, and allosteric activation
has been proposed [28,29].
The mechanism of allosteric activation of the ArsA
ATPase has been elucidated at the molecular level. In
brief, the allosteric site is composed of residues from
both the A1 and A2 halves, and binding of the acti-
vator brings the two halves together, such that the
two NBDs have an interface where catalysis is accel-
erated. The rate-limiting step in the overall reaction
is neither substrate binding nor product release.
Rather, the enzyme undergoes a conformational
change that is slow in the unactivated state. Binding
of the allosteric activator increases the rate of move-
ment of the enzyme through this conformation, ac-
celerating catalysis. It is possible that conformational
change may be rate-limiting in the mechanism of
some ABC transporters.
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